Dr. Rachel Elsey is the Cancer Genomics Pharmacy Coordinator at Avera Cancer Institute, leading research into the impact of genomic and multi-omic biomarkers on cancer treatment responses. She serves as primary investigator for the Avera Cancer Sequencing and Analytics Protocol (ASAP Study), a comprehensive initiative integrating genomics, transcriptomics, proteomics, pharmacogenomics, microbiome analysis, social determinants of health (SDOH), and real-world patient data to advance understanding of cancer development and personalize treatment strategies.
Scientific Research Expertise
Dr. Elsey leads the Molecular Tumor Board, facilitating multidisciplinary review of genomic data, biomarkers, and individual patient needs to inform treatment recommendations and optimize patient care.
She holds appointments demonstrating a commitment to medical and pharmaceutical education that focuses on clinical research.
- Assistant professor of Internal Medicine at University of South Dakota Sanford School of Medicine
- Adjunct faculty at the University of Iowa College of Pharmacy
- Precepts students from the University of Kansas College of Pharmacy and the PGY2 Oncology Residency at Avera McKennan
View Research Publications
